Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Moderna, Inc. is a biotechnology company specializing in mRNA technology to develop vaccines and therapeutics across infectious diseases, oncology, and rare conditions. Its core products include COVID-19 and RSV vaccines, with a pipeline of vaccines targeting influenza, herpes, HIV, and other viruses. The company leverages its platform for rapid development, manufacturing efficiency, and broad applicability, serving global markets with a focus on innovative, gene-based medicines.
This description was generated via AI from an annual report. Updated about 1 year ago.